Abstract |
Coronavirus disease 2019 (COVID-19) disrupts the intestinal micro-ecological balance, and patients often develop the intestinal disease. The gut is the largest immune organ in the human body; intestinal microbes can affect the immune function of the lungs through the gut-lung axis. It has been reported that tea polyphenols (TPs) have antiviral and prebiotic activity. In this review, we discussed TPs reduced lung-related diseases through gut-lung axis by inhibiting dysbiosis. In addition, we also highlighted the preventive and therapeutic effects of TPs on COVID-19 complications, further demonstrating the importance of research on TPs for the prevention and treatment of COVID-19 in humans. Based on this understanding, we recommend using TPs to regulate the gut microbiota to prevent or alleviate COVID-19 through the gut-lung axis.
|
Authors | Lei Xu, Chi-Tang Ho, Yanan Liu, Zufang Wu, Xin Zhang |
Journal | Frontiers in nutrition
(Front Nutr)
Vol. 9
Pg. 899842
( 2022)
ISSN: 2296-861X [Print] Switzerland |
PMID | 35495940
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2022 Xu, Ho, Liu, Wu and Zhang. |